Transgene S.A. buy metanicnor
Start price
31.05.14
/
50%
€9.91
Target price
18.05.15
€14.00
Performance (%)
-50.20%
End price
18.05.15
€4.94
Summary
This prediction ended on 18.05.15 with a price of €4.94. The BUY prediction by metanicnor for Transgene S.A. performed very badly with a performance of -50.20%. metanicnor has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Transgene S.A. | -4.452% | -4.452% | -31.782% | -51.138% |
| iShares Core DAX® | 0.000% | -2.064% | 13.111% | 16.685% |
| iShares Nasdaq 100 | 0.626% | -2.884% | 37.744% | 43.441% |
| iShares Nikkei 225® | 1.568% | -5.892% | 19.592% | 4.617% |
| iShares S&P 500 | 0.334% | -2.281% | 27.745% | 41.046% |
Comments by metanicnor for this prediction
In the thread Transgene S.A. diskutieren
TG4010
Vielversprechende Ergebnisse einer Studie über TG4010
bald in Phase-III-sein?
Transgen suche einen Finanzpartner
Termin im September 2014 detaillierte Ergebnisse auf TG4010
(Laufzeit überschritten)